01-03-2007
Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: A double-blind, randomised study
Published in: Quality of Life Research | Issue 2/2007
Login to get access